Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
449 | 23681 | 38.6 | 74% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3 | 1868053 | POLYMER SCIENCE//ENGINEERING, CHEMICAL//CHEMISTRY, PHYSICAL |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
520 | 14322 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION |
2307 | 4094 | HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION |
3080 | 1890 | ANTISECRETORY FACTOR//LOTEPREDNOL ETABONATE//METADOXINE |
3272 | 1420 | L ASPARAGINASE//ASPARAGINASE//ERWINIA ASPARAGINASE |
3349 | 1249 | CARRIER ERYTHROCYTES//VASCULAR IMMUNOTARGETING//NANOERYTHROSOMES |
3744 | 706 | POLYNUCLEOTIDE ANALOGUE//QUIM FARMACEUT ORGAN//BENZODIOXEPINS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SOLID LIPID NANOPARTICLES | Author keyword | 796 | 77% | 2% | 543 |
2 | L ASPARAGINASE | Author keyword | 252 | 65% | 1% | 239 |
3 | NANOSTRUCTURED LIPID CARRIERS | Author keyword | 247 | 78% | 1% | 163 |
4 | NANOSUSPENSION | Author keyword | 194 | 72% | 1% | 154 |
5 | POLYMERIC MICELLES | Author keyword | 190 | 50% | 1% | 271 |
6 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | Journal | 155 | 10% | 6% | 1463 |
7 | DRUG DELIVERY | Author keyword | 147 | 11% | 5% | 1232 |
8 | NANOEMULSION | Author keyword | 142 | 45% | 1% | 237 |
9 | HPMA COPOLYMERS | Author keyword | 137 | 91% | 0% | 58 |
10 | NANO EMULSIONS | Author keyword | 132 | 55% | 1% | 166 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SOLID LIPID NANOPARTICLES | 796 | 77% | 2% | 543 | Search SOLID+LIPID+NANOPARTICLES | Search SOLID+LIPID+NANOPARTICLES |
2 | L ASPARAGINASE | 252 | 65% | 1% | 239 | Search L+ASPARAGINASE | Search L+ASPARAGINASE |
3 | NANOSTRUCTURED LIPID CARRIERS | 247 | 78% | 1% | 163 | Search NANOSTRUCTURED+LIPID+CARRIERS | Search NANOSTRUCTURED+LIPID+CARRIERS |
4 | NANOSUSPENSION | 194 | 72% | 1% | 154 | Search NANOSUSPENSION | Search NANOSUSPENSION |
5 | POLYMERIC MICELLES | 190 | 50% | 1% | 271 | Search POLYMERIC+MICELLES | Search POLYMERIC+MICELLES |
6 | DRUG DELIVERY | 147 | 11% | 5% | 1232 | Search DRUG+DELIVERY | Search DRUG+DELIVERY |
7 | NANOEMULSION | 142 | 45% | 1% | 237 | Search NANOEMULSION | Search NANOEMULSION |
8 | HPMA COPOLYMERS | 137 | 91% | 0% | 58 | Search HPMA+COPOLYMERS | Search HPMA+COPOLYMERS |
9 | NANO EMULSIONS | 132 | 55% | 1% | 166 | Search NANO+EMULSIONS | Search NANO+EMULSIONS |
10 | SMEDDS | 128 | 90% | 0% | 55 | Search SMEDDS | Search SMEDDS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SLN | 706 | 82% | 2% | 411 |
2 | POLYMERIC MICELLES | 493 | 44% | 4% | 861 |
3 | LIPOPHILIC DRUGS | 333 | 72% | 1% | 261 |
4 | NANOPARTICLES SLN | 316 | 83% | 1% | 179 |
5 | SOLID LIPID NANOPARTICLES | 252 | 40% | 2% | 502 |
6 | BLOCK COPOLYMER MICELLES | 246 | 32% | 3% | 627 |
7 | SEDDS | 216 | 95% | 0% | 73 |
8 | NANOSUSPENSIONS | 208 | 65% | 1% | 196 |
9 | NANO EMULSIONS | 204 | 58% | 1% | 238 |
10 | ERWINIA ASPARAGINASE | 195 | 95% | 0% | 63 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 155 | 10% | 6% | 1463 |
2 | JOURNAL OF CONTROLLED RELEASE | 123 | 13% | 4% | 878 |
3 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 41 | 11% | 1% | 354 |
4 | JOURNAL OF DRUG TARGETING | 36 | 15% | 1% | 214 |
5 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 34 | 11% | 1% | 278 |
6 | MOLECULAR PHARMACEUTICS | 27 | 10% | 1% | 259 |
7 | DRUG DELIVERY | 25 | 16% | 1% | 144 |
8 | JOURNAL OF MICROENCAPSULATION | 18 | 10% | 1% | 170 |
9 | JOURNAL OF BIOMEDICAL NANOTECHNOLOGY | 14 | 10% | 1% | 132 |
10 | JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS | 12 | 12% | 0% | 95 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles | 2006 | 1100 | 78 | 79% |
Nanoparticle therapeutics: an emerging treatment modality for cancer | 2008 | 1398 | 85 | 44% |
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art | 2000 | 1062 | 55 | 91% |
Strategies in the design of nanoparticles for therapeutic applications | 2010 | 821 | 151 | 40% |
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery | 2013 | 153 | 77 | 60% |
The dawning era of polymer therapeutics | 2003 | 1763 | 105 | 50% |
Polymer conjugates as anticancer nanomedicines | 2006 | 881 | 100 | 66% |
Site-specific antibody drug conjugates for cancer therapy | 2014 | 54 | 67 | 55% |
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery | 2013 | 183 | 420 | 44% |
Nanocarriers as an emerging platform for cancer therapy | 2007 | 2208 | 93 | 24% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACEUT BIOPHARMACEUT BIOTECHNOL | 96 | 74% | 0.3% | 70 |
2 | POLYMER THER EUT | 62 | 59% | 0.3% | 69 |
3 | PHARMACEUT BIOPHARMACEUT NUTRICOSMET | 60 | 74% | 0.2% | 45 |
4 | SMART DRUG DELIVERY | 56 | 39% | 0.5% | 113 |
5 | NANOSCI NANOENGN INITIAT NUSNNI | 51 | 91% | 0.1% | 21 |
6 | PHARMACEUT PHARMACEUT CHEM | 30 | 17% | 0.7% | 158 |
7 | SHENZHEN GENE ANTIBODY THER Y | 26 | 56% | 0.1% | 31 |
8 | BIOMED POLYMERS | 25 | 18% | 0.5% | 128 |
9 | U646 | 23 | 36% | 0.2% | 52 |
10 | CAROLINA CANC NANOTECHNOL EXCELLENCE | 22 | 54% | 0.1% | 29 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000007934 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//SOLID DISPERSIONS |
2 | 0.0000005194 | DENDRIMERS//DENDRIMER//OXIDATIVE POLYCONDENSATION |
3 | 0.0000003974 | POLYMER SCIENCE//MACROMOLECULES//HYDROGEL |
4 | 0.0000003884 | GENE DELIVERY//GENE THERAPY//ANTIMICROBIAL PEPTIDE |
5 | 0.0000003559 | LANGMUIR//JOURNAL OF COLLOID AND INTERFACE SCIENCE//LANGMUIR BLODGETT FILMS |
6 | 0.0000003294 | POLYHYDROXYALKANOATES//POLYHYDROXYALKANOATE//POLY3 HYDROXYBUTYRATE |
7 | 0.0000002626 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
8 | 0.0000002218 | JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES//ELECTRORHEOLOGICAL FLUID//MAGNETIC NANOPARTICLES |
9 | 0.0000002177 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//SGLT2 INHIBITOR |
10 | 0.0000002147 | TIGHT JUNCTION//CLAUDIN//OCCLUDIN |